Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02820753 · ClinicalTrials.gov registry record · NA
A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 677
- Enrollment target
NCT02820753 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 677 participants.
The verdict
NCT02820753, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 677 participants
- Enrollment target
Study Summary
This study will leverage available technologies and test strategies to impart the Universal Medication Schedule (UMS) in primary care to help patients understand, consolidate, safely use, and adhere to their complex medication regimens.
Interventions
- BEHAVIORAL EHR + (Text or Portal)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 677 participants |
| Start Date | 2017-04-03 |
| Est. Completion | 2020-09-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02820753
The ClinicalTrials.gov registry entry for NCT02820753 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 677 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EHR + (Text or Portal) is the first listed.
NCT02820753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02820753 about?
NCT02820753 is a clinical study titled "A Universal Medication Schedule to Promote Adherence to Complex Drug Regimens". This study will leverage available technologies and test strategies to impart the Universal Medication Schedule (UMS) in primary care to help patients understand, consolidate, safely use, and adhere to their complex medication regimens.
What is the current status of trial NCT02820753?
This trial is currently completed. It is a NA study. The enrollment target is 677 participants. The study started on 2017-04-03. Estimated completion is 2020-09-21.
What interventions are being tested in trial NCT02820753?
The interventions under investigation include: EHR + (Text or Portal) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02820753?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.